Protheragen Obesity Announces Full Preclinical Services and...

Ajouter une nouvelle offre d'emploi Health

2026-09-29 04:12:02 -

Protheragen Obesity Announces Full Preclinical Services and Research Products for Obesity Drug Development

Developing a new obesity drug requires multiple steps: target validation, pharmacokinetic studies, safety assessments, and more. Protheragen Obesity is a Contract Research Organization (CRO) that provides exactly these services, with a focus on the preclinical stage. The company recently announced its full range of service offerings and research products. According to its website,...

0 Commentaires 0 Parts 71 Vue 0 Aperçu